These mutations can result in enhanced TLR signaling, leading to molecules, including intercellular adhesion molecule-1, IL-6, E-selectin, MCP-1, and MMP1/3, were individually linked to PAD [84]. The gene discussed is ICAM1; the disease is peripheral arterial disease.